Employees: 12 (2023.0)Legal category: 5485Size: PMECreation date: 1982-03-15 (44 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MOULINS (03000), Allier
PHARMACIE MOULINS SUD : revenue, balance sheet and financial ratios
PHARMACIE MOULINS SUD is a French company
founded 44 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MOULINS (03000),
this company of category PME
shows in 2022 a revenue of 6.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE MOULINS SUD (SIREN 324115906)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
2016
Revenue
N/C
N/C
6 114 376 €
N/C
N/C
N/C
N/C
N/C
N/C
2 351 407 €
Net income
254 535 €
279 164 €
618 612 €
132 568 €
203 419 €
250 924 €
204 242 €
139 023 €
48 754 €
85 055 €
EBITDA
N/C
N/C
940 841 €
N/C
N/C
N/C
N/C
N/C
N/C
122 923 €
Net margin
N/C
N/C
10.1%
N/C
N/C
N/C
N/C
N/C
N/C
3.6%
Revenue and income statement
In 2024, PHARMACIE MOULINS SUD generates positive net income of 255 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 85 k€ -> 255 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
254 535 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 171%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 29%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
171.296%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
28.585%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE MOULINS SUD
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
123.331
32.631
76.477
87.603
60.029
49.495
173.513
89.112
161.589
171.296
Financial autonomy
25.73
33.697
31.217
40.925
47.402
50.782
26.581
37.331
29.241
28.585
Repayment capacity
2.49
None
None
None
None
None
None
1.443
None
None
Cash flow / Revenue
3.843%
None%
None%
None%
None%
None%
None%
11.97%
None%
None%
Sector positioning
Debt ratio
171.32024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average+22 pts over 3 years
In 2024, the debt ratio of PHARMACIE MOULINS SUD (171.30) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
28.59%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average-12 pts over 3 years
In 2024, the financial autonomy of PHARMACIE MOULINS SUD (28.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
1.44 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Good
In 2022, the repayment capacity of PHARMACIE MOULINS SUD (1.44) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 261.27. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
261.268
Liquidity indicators evolution PHARMACIE MOULINS SUD
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
105.801
81.514
147.395
227.676
235.422
249.708
192.085
211.179
226.111
261.268
Interest coverage
2.465
None
None
None
None
None
None
0.575
None
None
Sector positioning
Liquidity ratio
261.272024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent+21 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE MOULINS SUD (261.27) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
0.57x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average
In 2022, the interest coverage of PHARMACIE MOULINS SUD (0.6x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE MOULINS SUD
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
293 808 €
0 €
0 €
0 €
0 €
0 €
0 €
1 262 435 €
0 €
0 €
Inventory turnover (days)
47
0
0
0
0
0
0
81
0
0
Customer payment term (days)
1
0
0
0
0
0
0
1
0
0
Supplier payment term (days)
46
0
0
0
0
0
0
50
0
0
Positioning of PHARMACIE MOULINS SUD in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE MOULINS SUD is estimated at
3 553 496 €
(range 2 474 598€ - 5 316 234€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
2474k€3553k€5316k€
3 553 496 €Range: 2 474 598€ - 5 316 234€
NAF 5 année 2024
Valuation method used
Net Income Multiple
254 535 €
×
14.0x
=3 553 497 €
Range: 2 474 599€ - 5 316 234€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE MOULINS SUD with other companies in the same sector:
Frequently asked questions about PHARMACIE MOULINS SUD
What is the revenue of PHARMACIE MOULINS SUD ?
The revenue of PHARMACIE MOULINS SUD in 2022 is 6.1 M€.
Is PHARMACIE MOULINS SUD profitable?
Yes, PHARMACIE MOULINS SUD generated a net profit of 255 k€ in 2024.
Where is the headquarters of PHARMACIE MOULINS SUD ?
The headquarters of PHARMACIE MOULINS SUD is located in MOULINS (03000), in the department Allier.
Where to find the tax return of PHARMACIE MOULINS SUD ?
The tax return of PHARMACIE MOULINS SUD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE MOULINS SUD operate?
PHARMACIE MOULINS SUD operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart